Eli Lilly BDCL

Enroll Now

Type of Study:

Trial evaluates 2 dose schedules for LY3209590 in comparison to daily insulin Degludec

Title of Study:

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Short Title:

BDCL

Study Length: 26 Weeks

Target Age/Sex: over 18 years, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov